Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 564 Print this page  Email this page Small font size Default font size Increase font size

 Table of Contents     
Year : 2018  |  Volume : 33  |  Issue : 1  |  Page : 91  

Reply by Author

Date of Web Publication16-Jan-2018

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0972-3919.223249

Rights and Permissions

How to cite this article:
. Reply by Author. Indian J Nucl Med 2018;33:91

How to cite this URL:
. Reply by Author. Indian J Nucl Med [serial online] 2018 [cited 2023 Mar 30];33:91. Available from:

Dear Sir,

Thank you very much for reading our article and your positive comments thereof.

Although you are in sync with our thought process of using the FDG PET in the scenario of discussed cases, your suggestion to do a larger prospective series is welcome. One scientific point that might be considered is the use of 18F-FLT. It is more marrow specific and in leukemias may add to be more specific.

- Dr. Venkatesh Rangarajan


    Similar in PUBMED
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded66    
    Comments [Add]    

Recommend this journal